After Adverse Legal Ruling, Myriad Quickly Settles BRCA Litigation…1 Quest’s Latest Earnings Report Suggests Growth Is Gaining Momentum…1 Claritas Raises $15 Million in Funding…3 Palmetto Institutes New LCD Regarding Biopsy Stains…2   INSIDE THE LABORATORY INDUSTRY Speeding Up of Value-Based Payments Could Be Clarion Call for Lab Sector…4   INDUSTRY BUZZ 23andMe Motion Sickness Study May Be Part of Plan to Remake Company…8

After Adverse Legal Ruling, Myriad Quickly Settles BRCA Litigation...1 Quest’s Latest Earnings Report Suggests Growth Is Gaining Momentum...1 Claritas Raises $15 Million in Funding...3 Palmetto Institutes New LCD Regarding Biopsy Stains...2   INSIDE THE LABORATORY INDUSTRY Speeding Up of Value-Based Payments Could Be Clarion Call for Lab Sector...4   INDUSTRY BUZZ 23andMe Motion Sickness Study May Be Part of Plan to Remake Company...8

Sign up for our free weekly Lab & Pathology Insider email newsletter

Subscribe to view Essential

Start a Free Trial for immediate access to this article